![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T Unger
Department of Pharmacology, University of Heidelberg, Germany.
The central actions of angiotensin II (ANG II) include the release of vasopressin (AVP) from the supraoptic nucleus (SON) via the pituitary gland into the blood. In conscious rats, we investigated whether catecholamines in the SON are involved in this release process. It was found that i.c.v. injections of ANG II (100 ng) selectively increased the release of norepinephrine (NA) from the SON. Like the ANG II i.c.v.- induced AVP release, this effect was prevented by i.c.v. pretreatment with the ANG II AT1 receptor antagonist, losartan (5 micrograms). The alpha-1 adrenoceptor antagonist, prazosin (0.7 nmol), injected bilaterally into the SON, significantly reduced the ANG II 100-ng i.c.v.-induced AVP release. Pretreatment with the alpha-2, beta-1 and beta-2 adrenoceptor antagonists, idazoxan, atenolol and ICI 118551, respectively, had no effect. Injections of NA into the SON increased plasma AVP at doses up to 10 nmol but not at higher doses (30-100 nmol). The effects of NA were mimicked by the alpha-1 adrenoceptor agonist, methoxamine (1-5 nmol). Bilateral pretreatment of the SON with losartan (5 micrograms) markedly inhibited the i.c.v. ANG II 100 ng- induced AVP release. The increase in AVP release after ANG II injections into the SON was also inhibited by losartan pretreatment into the SON, whereas prazosin had no effect. These results demonstrate that the ANG II-induced release of AVP is initiated through periventricular ANG II AT1 receptors and involves postsynaptic alpha-1 adrenoceptor stimulation in the SON. In addition, ANG II AT1 receptors in the SON can contribute to AVP release after periventricular ANG II receptor stimulation.
This article has been cited by other articles:
|
|
 |
|
  W. K Samson, G. L C Yosten, J.-K. Chang, A. V Ferguson, and M. M White Obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis J. Endocrinol., March 1, 2008; 196(3): 559 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, P. J. Flannery, K. Athirakul, S. R. Dunn, W. M. Kourany, and R. F. Spurney G{alpha}q-dependent signaling cascades stimulate water-seeking behavior Am J Physiol Renal Physiol, October 1, 2006; 291(4): F781 - F789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, H. Chen, and M. Morris Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors Exp Physiol, September 1, 2005; 90(5): 739 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bedard, B. Sicotte, J. St-Louis, and M. Brochu Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction J. Physiol., February 1, 2005; 562(3): 937 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rigatto, R. Puryear, I. Bernatova, and M. Morris Salt Appetite and the Renin-Angiotensin System: Effect of Oxytocin Deficiency Hypertension, October 1, 2003; 42(4): 793 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Fleegal and C. Sumners Drinking behavior elicited by central injection of angiotensin II: roles for protein kinase C and Ca2+/calmodulin-dependent protein kinase II Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R632 - R640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Staahltoft, S. Nielsen, N. R. Janjua, S. Christensen, O. Skott, N. Marcussen, and T. E. N. Jonassen Losartan treatment normalizes renal sodium and water handling in rats with mild congestive heart failure Am J Physiol Renal Physiol, February 1, 2002; 282(2): F307 - F315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Busche, S. Gallinat, M. A. Fleegal, M. K. Raizada, and C. Sumners Novel Role of Macrophage Migration Inhibitory Factor in Angiotensin II Regulation of Neuromodulation in Rat Brain Endocrinology, November 1, 2001; 142(11): 4623 - 4630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gohlke, S. Weiss, A. Jansen, W. Wienen, J. Stangier, W. Rascher, J. Culman, and T. Unger AT1 Receptor Antagonist Telmisartan Administered Peripherally Inhibits Central Responses to Angiotensin II in Conscious Rats J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 62 - 70. [Abstract] [Full Text]
|
|
|
|
 |
|
 S.-J. Pan, M. Zhu, M. K. Raizada, C. Sumners, and C. H. Gelband ANG II-mediated inhibition of neuronal delayed rectifier K+ current: role of protein kinase C-{alpha} Am J Physiol Cell Physiol, July 1, 2001; 281(1): C17 - C23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gallinat, S. Busche, H. Yang, M. K. Raizada, and C. Sumners Gene Expression Profiling of Rat Brain Neurons Reveals Angiotensin II-Induced Regulation of Calmodulin and Synapsin I: Possible Role in Neuromodulation Endocrinology, March 1, 2001; 142(3): 1009 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners The angiotensin II type 2 receptor: an enigma with multiple variations Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Oliverio, M. Delnomdedieu, C. F. Best, P. Li, M. Morris, M. F. Callahan, G. A. Johnson, O. Smithies, and T. M. Coffman Abnormal water metabolism in mice lacking the type 1A receptor for ANG II Am J Physiol Renal Physiol, January 1, 2000; 278(1): F75 - F82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhu, C. H. Gelband, P. Posner, and C. Sumners Angiotensin II Decreases Neuronal Delayed Rectifier Potassium Current: Role of Calcium/Calmodulin-Dependent Protein Kinase II J Neurophysiol, September 1, 1999; 82(3): 1560 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Gelband, J. D. Warth, H. S. Mason, M. Zhu, J. M. Moore, J. L. Kenyon, B. Horowitz, and C. Sumners Angiotensin II Type 1 Receptor–Mediated Inhibition of K+ Channel Subunit Kv2.2 in Brain Stem and Hypothalamic Neurons Circ. Res., February 19, 1999; 84(3): 352 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. V. Shenoy, E. M. Richards, X.-C. Huang, and C. Sumners Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain Endocrinology, January 1, 1999; 140(1): 500 - 509. [Abstract] [Full Text]
|
|
|
|
|
|
M. Morris, P. Li, M. F. Callahan, M. I. Oliverio, T. M. Coffman, S. M. Bosch, and D. I. Diz Neuroendocrine Effects of Dehydration in Mice Lacking the Angiotensin AT1a Receptor Hypertension, January 1, 1999; 33(1): 482 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Rossi Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E687 - E693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Qadri, T. Waldmann, A. Wolf, S. Höhle, W. Rascher, and T. Unger Differential Contribution of Angiotensinergic and Cholinergic Receptors in the Hypothalamic Paraventricular Nucleus to Osmotically Induced AVP Release J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1012 - 1018. [Abstract] [Full Text]
|
|
|
|
|
|
X.-C. Huang, T. Deng, and C. Sumners Angiotensin II Stimulates Activation of Fos-Regulating Kinase and c-Jun NH2-Terminal Kinase in Neuronal Cultures from Rat Brain Endocrinology, January 1, 1998; 139(1): 245 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Muders, D. Elsner, K. Jandeleit, U. Bahner, E. P. Kromer, I. Kirst, G. A.J. Riegger, and M. Palkovits Chronic ACE inhibition by quinapril modulates central vasopressinergic system Cardiovasc Res, June 1, 1997; 34(3): 575 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Blume, C. J. Lebrun, T. Herdegen, R. Bravo, W. Linz, E. Mollenhoff, and T. Unger Increased Brain Transcription Factor Expression by Angiotensin in Genetic Hypertension Hypertension, February 1, 1997; 29(2): 592 - 598. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
